Biodexa Pharmaceuticals PLC
13F holders, Q1 2024 (March 31)5holders
$1.62avg. 13F price*
At the end of Q1 2024, 5 institutions reported holding Biodexa Pharmaceuticals PLC in their 13F filings. The largest holders were GAMMA Investing LLC ($18K), Bank of America Corp. ($8K) and UBS Group AG ($4K).
- Company
- Biodexa Pharmaceuticals PLC
- CUSIP
- 59564R708
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $151K |
Ownership 5 holders
| GAMMA Investing LLC | 0.00% | Add +971.5% | 11,101 | $18K |
| Bank of America Corp. | 0.00% | No change | 5,236 | $8K |
| UBS Group AG | 0.00% | Add +306.3% | 2,438 | $4K |
| Rhumbline Advisers | 0.00% | No change | 498 | $806 |
| Morgan Stanley | 0.00% | No change | 16 | $26 |
"% of holder's portfolio" is BIODEXA PHARMACEUTICALS PLC's weight in each manager's 13F, not the share of Biodexa Pharmaceuticals PLC the manager owns.